Journals / Göztepe Tıp Dergisi / 2007 / Cilt: 22 - Sayı: 4

The evaluation of the resistance rates of Staphylococcus aureus strains to antimicribials according to the years

Yıllara göre Staphylococcus aureus suşlarında antimikrobiyallere karşı direnç gelişiminin incelenmesi

Pages
137–139
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

At two periods the resistance was not established to vancomycin; but, it was established an increase statistically unsignificant at the second period, amikacin, teicoplanin, gentamicin, tetracycline, oxacillin and eritromycin but increase in to ciprofloxacin and rifampicin significantly.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In our hospital, sensitivity tests of 290 Staphylococcus aureus strains isolated in 1998-2000 years and 280 Staphylococcus aureus strains isolated in 2003-2004 years were performed and investigated the alterations on resistance rates.
📊
Key Findings & Data:In our hospital, sensitivity tests of 290 Staphylococcus aureus strains isolated in 1998-2000 years and 280 Staphylococcus aureus strains isolated in 2003-2004 years were performed and investigated the alterations on resistance rates.
💡
Conclusion & Impact:At two periods the resistance was not established to vancomycin; but, it was established an increase statistically unsignificant at the second period, amikacin, teicoplanin, gentamicin, tetracycline, oxacillin and eritromycin but increase in to ciprofloxacin and rifampicin significantly.
🔬Design:Research Article
📍Scope:2000 Verileri
⚙️Variables:Domain Parameters

Abstract

In our hospital, sensitivity tests of 290 Staphylococcus aureus strains isolated in 1998-2000 years and 280 Staphylococcus aureus strains isolated in 2003-2004 years were performed and investigated the alterations on resistance rates. At two periods the resistance was not established to vancomycin; but, it was established an increase statistically unsignificant at the second period, amikacin, teicoplanin, gentamicin, tetracycline, oxacillin and eritromycin but increase in to ciprofloxacin and rifampicin significantly.

Özet

Hastanemizde 1998-2000 yıllarında izole edilen 290 ve 2003-2004 yıllarında izole edilen 280 Staphylococcus aureus suşu-nun direnç oranlarındaki değişiklikler araştırıldı. S. aureus suşlarında her iki dönemde de vankomisine direnç saptanmadı, ikinci dönemde amikasin, teikoplanin, gentamisin, tetrasiklin, oksasilin ve eritromisine karşı istatistiksel olarak anlamsız, siprofloksasin ve rifampisine karşı ise anlamlı bir direnç artışı saptandı.

🔖

Cite This Article

BOZKURT, H., BAYRAM, Y., BERKTAŞ, M., KURTOĞLU, M. G. (2022). The evaluation of the resistance rates of Staphylococcus aureus strains to antimicribials according to the years. Göztepe Tıp Dergisi, Cilt: 22 - Sayı: 4, 137–139. https://ajindex.com/articles/526293

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Joklik WK, Willett HP, Amos DB, Wilfert CM: Zinsser’s Microbiology 20nd. Ed., London, 401, 1995
  2. Kayser HF: Methicillin and glycopeptide resistance in staphylococci: a new threat, Curr Opin Infect Dis 8:7, 1995
  3. Smith SM, Mangia A, Eng RHK, Ruggeri P, Cytryn A, Tecson TF: Clindamycin for colonization and infection by methicillin-resistant Staphylococcus aureus. Infect Dis 16:95, 1998
  4. Cengiz AT: Staphylococcus, Ustaçelebi Ş (Ed), “Temel ve Klinik Mikrobiyoloji” kitabında, 1. Baskı, Güneş Kitabevi, Ankara, 339, 1999
  5. Hsueh PR, Teng LJ, Chen WH et al: Increasing prevalence of meticillin-resistant Staphylococcus aureus causing nosocomial infections at a university hospital in Taiwan from 1986 to 2001. Antimicrob Agents Chemother 48:1361, 2004
  6. Bilgehan H: Klinik Mikrobiyolojik Tanı, 3. Baskı, Şafak Matbaacılık, Ankara 495, 2002
  7. Chambers HF: The changing epidemiology of Staphylococcus aureus? Emerg Infect Dis 7:178, 2001
  8. Fridkin SK, Hill HA, Volkova NV et al: Temporal changes in prevalence of antimicrobial resistance in 23 US hospitals. Emerg Infect Dis 8:697, 2002
  9. Altoparlak Ü, Uslu H, Kireççi E, Aktaş F: Klinik örneklerden izole edilen stafilokoklarda antibiyotik direnci. ANKEM Derg 16:69, 2002
  10. Değerli K, Özbakkaloğlu B, Sürücüoğlu S, Sezgin C, Kurutepe S: Klinik örneklerden soyutlanan Staphylococcus aureus suşlarının çeşitli antimikrobiklere duyarlılıkları. ‹nfeksiyon Derg 14:87, 2000
  11. Demir M, Kaleli ‹, Cevahir N, Mete E: Çeşitli klinik örneklerden soyutlanan Staphylococcus aureus suşlarında antibiyotik direnci. ANKEM Derg 17:56, 2003
  12. Kaleli ‹, Şengül M, Özen M, Akşit F: Staphylococcus aureus suşlarının çeşitli antibiyotiklere duyarlılığı. ‹nfeksiyon Derg 12:351, 1998
  13. Arıbaş ET, Özcan M, Altındiş M: Klinik örneklerden izole edilen stafilokokların antibiyotik direnç oranları. ‹nfeksiyon Derg 15:73, 2001
  14. Kim HB, Jang HC, Nam HJ et al: In vitro activities of 28 antimicrobial agents against Staphylococcus aureus isolates from tertiary-care hospitals in Korea: a nationwide survey. Antimicrob Agent Chemother 48:1124, 2004
  15. Kacica M, Mc Donald L: Brief Report: Vancomycin- resistant Staphylococcus aureus New-York 2004. MMWR 53:322, 2004
  16. Jones RN, Barry LA, Gardiner VR, Packer RR: The prevalance of staphylococcal resistance to penicillinase-resistant penicillins. A retrospective and prospective national surveillance trial of isolates from 40 medical centers. Diagn Microbiol Infect Dis 12:385, 1989. 17.